Modulation of carcinogen-metabolizing cytochromes P450 by phytochemicals in humans

被引:22
作者
Baer-Dubowska, Wanda [1 ]
Szaefer, Hanna [1 ]
机构
[1] Poznan Univ Med Sci, Dept Pharmaceut Biochem, PL-60781 Poznan, Poland
关键词
cell cultures; cytochromes P450; human intervention trials; PCLS; phytochemicals; ARYL-HYDROCARBON RECEPTOR; GREEN TEA EXTRACT; PRIMARY HUMAN HEPATOCYTES; HUMAN LIVER-MICROSOMES; GINKGO-BILOBA EXTRACT; OXIDATIVE DNA-DAMAGE; BREAST-CANCER CELLS; HUMAN CYP1 ENZYMES; HEPG2; CELLS; TRANS-RESVERATROL;
D O I
10.1517/17425255.2013.795219
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Cytochrome P450 (CYP) families 1 - 3, besides oxidizing environmental and dietary chemicals, leading to their elimination, catalyze the bioactivation of exogenous as well as endogenous carcinogens. Phytochemicals, particularly those which are active food components, were shown to be able to affect specific CYP expression and/or activity in animal models and in human in vitro systems. Human intervention studies involving healthy volunteers were also performed. This review describes human CYP modulation by naturally occurring phytochemicals which can not only affect carcinogen metabolism in humans, but also change the drug response. Areas covered: The authors present an overview of carcinogens metabolizing human CYP modulation in different model systems as well as studies on human dietary intervention. Furthermore, the authors provide examples of the phytochemicals that affect CYP expression and activity. Expert opinion: CYP, which are involved in carcinogen activation, can metabolize a range of substrates and inducing CYP by one substrate may also increase the metabolism of another. The ultimate proof of the efficacy of CYP modulation strategy for chemoprevention may be provided by clinical trials involving risk populations, which are difficult to perform. The new human-like models are highly desired for the study of modulation of carcinogen-metabolizing CYP.
引用
收藏
页码:927 / 941
页数:15
相关论文
共 99 条
[1]   Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human HepG2 cells [J].
Anwar-Mohamed, Anwar ;
El-Kadi, Ayman O. S. .
CANCER LETTERS, 2009, 275 (01) :93-101
[2]  
Bacr-Dubowska W, 2011, PHARM REP, V63, P293
[3]  
Baer-Dubowska W, 2006, C F P F C S, P177
[4]   Resveratrol Inhibits Dioxin-Induced Expression of Human CYP1A1 and CYP1B1 by Inhibiting Recruitment of the Aryl Hydrocarbon Receptor Complex and RNA Polymerase II to the Regulatory Regions of the Corresponding Genes [J].
Beedanagari, Sudheer R. ;
Bebenek, Ilona ;
Bui, Peter ;
Hankinson, Oliver .
TOXICOLOGICAL SCIENCES, 2009, 110 (01) :61-67
[5]   The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1α, CYP1A1 and NQO1 genes in rat liver [J].
Brauze, Damian ;
Widerak, Magdalena ;
Cwykiel, Joanna ;
Szyfter, Krzysztof ;
Baer-Dubowska, Wanda .
TOXICOLOGY LETTERS, 2006, 167 (03) :212-220
[6]   Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes [J].
Cai, YN ;
BaerDubowska, W ;
AshwoodSmith, M ;
DiGiovanni, J .
CARCINOGENESIS, 1997, 18 (01) :215-222
[7]   Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity:: mechanisms in rat and human cells [J].
Cavin, C ;
Mace, K ;
Offord, EA ;
Schilter, B .
FOOD AND CHEMICAL TOXICOLOGY, 2001, 39 (06) :549-556
[8]   Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes:: Identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1 [J].
Chang, TKH ;
Chen, J ;
Yeung, EYH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 213 (01) :18-26
[9]  
Chang TKH, 2001, J PHARMACOL EXP THER, V299, P874
[10]   Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk Assessment [J].
Cheung, Connie ;
Gonzalez, Frank J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (02) :288-299